Inventiva Revises Phase III NASH Plans For Broader Indication

 
• By Joseph Haas
  
Change of plans
Inventiva's revised Phase III NASH plans involve testing drug in cirrhotic patients • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Clinical Trials

More from R&D